Prednisolone is a glucocorticoid similar to cortisol used for its anti-inflammatory, immunosuppressive, anti-neoplastic, and vasoconstrictive effects.
Prednisolone was granted FDA approval on 21 June 1955.
Prednisolone is indicated to treat endocrine, rheumatic, and hematologic disorders; collagen, dermatologic, ophthalmic, respiratory, and gastrointestinal diseases; allergic and edematous states; and other conditions like tuberculous meningitis.
Pakistan Institute of Medical Sciences, Islamabad, Capital, Pakistan
Faculty of Dentistry, Alexandria University, Alexandria, Egypt
Universitätsklinikum Erlangen, Erlangen, Bavaria, Germany
Research Site, Neuss, Germany
Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
Children's hospital of Fudan university, Shanghai, Shanghai, China
Shanghai Children's Hospital, Shanghai, China
Karmanos Cancer Institute, Detroit, Michigan, United States
Nuffield Department of Medicine, Oxford, United Kingdom
The first Affiliated Hospital Of Nanjing Medical University(JiangSu Province Hospital), Nanjing, Jiangsu, China
Center for Clinical Metabolic Research, Hellerup, Denmark
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.